<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Liebl MC</submitter><funding>Deutsche Forschungsgemeinschaft</funding><pagination>2759-2776</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7969023</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>49(5)</volume><pubmed_abstract>The DNA damage-responsive tumor suppressors p53 and HIPK2 are well established regulators of cell fate decision-making and regulate the cellular sensitivity to DNA-damaging drugs. Here, we identify Deleted in Azoospermia-associated protein 2 (DAZAP2), a small adaptor protein, as a novel regulator of HIPK2 and specifier of the DNA damage-induced p53 response. Knock-down or genetic deletion of DAZAP2 strongly potentiates cancer cell chemosensitivity both in cells and in vivo using a mouse tumour xenograft model. In unstressed cells, DAZAP2 stimulates HIPK2 polyubiquitination and degradation through interplay with the ubiquitin ligase SIAH1. Upon DNA damage, HIPK2 site-specifically phosphorylates DAZAP2, which terminates its HIPK2-degrading function and triggers its re-localization to the cel</pubmed_abstract><journal>Nucleic acids research</journal><pubmed_title>DAZAP2 acts as specifier of the p53 response to DNA damage.</pubmed_title><pmcid>PMC7969023</pmcid><funding_grant_id>SFB 1361</funding_grant_id><funding_grant_id>SFB 1036</funding_grant_id><pubmed_authors>Abdeen SK</pubmed_authors><pubmed_authors>Raddatz G</pubmed_authors><pubmed_authors>Liebl MC</pubmed_authors><pubmed_authors>Becker H</pubmed_authors><pubmed_authors>Aqeilan RI</pubmed_authors><pubmed_authors>Moehlenbrink J</pubmed_authors><pubmed_authors>Hofmann TG</pubmed_authors><pubmed_authors>Lyko F</pubmed_authors></additional><is_claimable>false</is_claimable><name>DAZAP2 acts as specifier of the p53 response to DNA damage.</name><description>The DNA damage-responsive tumor suppressors p53 and HIPK2 are well established regulators of cell fate decision-making and regulate the cellular sensitivity to DNA-damaging drugs. Here, we identify Deleted in Azoospermia-associated protein 2 (DAZAP2), a small adaptor protein, as a novel regulator of HIPK2 and specifier of the DNA damage-induced p53 response. Knock-down or genetic deletion of DAZAP2 strongly potentiates cancer cell chemosensitivity both in cells and in vivo using a mouse tumour xenograft model. In unstressed cells, DAZAP2 stimulates HIPK2 polyubiquitination and degradation through interplay with the ubiquitin ligase SIAH1. Upon DNA damage, HIPK2 site-specifically phosphorylates DAZAP2, which terminates its HIPK2-degrading function and triggers its re-localization to the cel</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Mar</publication><modification>2026-05-01T17:28:48.87Z</modification><creation>2024-11-13T06:29:03.4Z</creation></dates><accession>S-EPMC7969023</accession><cross_references><pubmed>33591310</pubmed><doi>10.1093/nar/gkab084</doi></cross_references></HashMap>